Return to Course LibraryCE InformationBibliography



Release Date
August 2012

Expiration Date
September 1, 2016


Stamatia Destounis, MD, FACR
Elizabeth Wende Breast Care
Clinical Associate Professor
University of Rochester Medical Center
Rochester, NY


Equipment Requirements

PC: Windows XP/Vista/Win7, Pentium processor or faster, at least 1 GB RAM, Internet Explorer version 8 and 9, Mozilla FireFox version 15.

MAC: OS version 10.6/10.7/10/8, Intel processor or faster, at least 1 GB RAM, Safari version 5, FireFox version 15.

Lessons Learned:
Digital Breast Tomosynthesis Implementation
in a Community-based Breast Imaging Practice

Recording of a live webinar presented on August 1, 2012

A certified one-hour recorded webinar for radiologists.

Format: Archived Webinar
MD Credit:  1.0 AMA PRA Category 1
(Available for physician credit only)
RT Credit:   No ARRT credit available
Fee for Credit Certificate: $0


Click the ENROLL NOW icon to the left to register for this program

Course Overview

In February 2011, the FDA approved digital breast tomosynthesis (DBT) for use in breast imaging. The approval of DBT adds to the already wide range of breast screening and diagnostic imaging options available to physicians.

With FDA approval of DBT, the medical community is faced with evaluating DBT in terms of providing improved care for their patient population and the impact of this new technology on their medical practice. This evaluation process involves consideration of the pros and cons of the technology compared to their current practice, operational concerns, and impact on patient care.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Evaluate the potential role of DBT for enhancing the screening and diagnosis of breast disease
  • Identify the types of patients who may benefit from digital breast tomosynthesis
  • Consider the operational and educational issues of integration of DBT into the clinical practice

Accreditation & Credit

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the International Center for Postgraduate Medical Education.The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to

How to Participate

There are no fees to participate in this activity.

  • Click the blue link. Complete the precourse evaluation and click SUBMIT.
  • Once the precourse evaluation is submitted, click on the blue link again to view the course.
  • Click on PLAYBACK. To view the streaming video, you may have to download the WebEx Player or Java.

Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.

How to Receive Credit

  • View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
  • At the conclusion of the lecture, close the WebEx Player window. You will be redirected to the ICPME website.
  • From the COURSE HOME page, click the buttons for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit.  You may take the test up to three times.
  • Upon receipt of a passing grade, click the certificate tab to print a credit certificate.

Faculty Biography

Dr. Destounis joined Elizabeth Wende Breast Care (EWBC) in Rochester, NY in 1993 after completing her Diagnostic Radiology Residency at the University of Rochester School of Medicine and Dentistry. She completed a breast imaging fellowship at EWBC with Dr. Wende Logan-Young and subsequently joined the faculty.

Dr. Destounis sits on the medical advisory boards of several breast imaging technology companies and is also a member of the American Cancer Society Medical Advisory Team. Within the Rochester community, Dr. Destounis has participated on radiology committees for several health care providers and is a volunteer for many community organizations. Dr. Destounis frequently lectures nationally and internationally to professional groups on a variety of radiological subjects, including mammography, ultrasound, MRI, biopsy techniques, and new modalities like elastography and digital breast tomosynthesis.

In 2010, Dr. Destounis was selected as a distinguished Fellow of the Society of Breast Imaging (SBI). This honor is given to Members of the Society for pursuing academic excellence, promoting teaching, education and research. In May 2011, Dr. Destounis was also honored as a Fellow by the American College of Radiology.

Dr. Destounis’ research interests include computer-aided detection, digital mammography, breast MRI, breast ultrasound, and breast biopsy. She has published several clinical and research peer-reviewed articles and is the principal investigator of several ongoing research projects.

Conflict of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty below have reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Stamatia Destounis, MD, FACR has performed contracted research for Hologic, Inc.

The planners and managers below reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino
Laura Excell, ND, NP, MS, MA, LPC, NCC
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME, and Hologic. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

For questions regarding this program, please contact ICPME:
Phone: 607-257-5860 x10




Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.